XRX
44
3
ACN
52
3
HAS
33
3
CAH
48
-5
SYY
53
4
ORCL
65
-2
VNO
60
10
UA
50
-9
RSG
71
3
VMC
57
4
GOOGL
40
-5
SNA
68
-2
AIV
72
2
R
71
4
NWS
66
-3
MA
64
7
GS
75
2
HCP
66
8
PLD
56
8
SO
53
-4
XRX
44
3
ACN
52
3
HAS
33
3
CAH
48
-5
SYY
53
4
ORCL
65
-2
VNO
60
10
UA
50
-9
RSG
71
3
VMC
57
4
GOOGL
40
-5
SNA
68
-2
AIV
72
2
R
71
4
NWS
66
-3
MA
64
7
GS
75
2
HCP
66
8
PLD
56
8
SO
53
-4
Financhill
Back

MEI Pharma Vs. Revance Therapeutics Industry Stock Comparison

Sell
41

MEIP
MEI Pharma

Last Price:
2.79
Seasonality Move:
-0.42%
Sell
9

RVNC
Revance Therapeutics

Last Price:
3.73
Seasonality Move:
6.97%
Sell
41
MEI Pharma (MEIP) is a Sell

Is MEI Pharma a Buy, Sell or Hold?

  • The current MEI Pharma [MEIP] share price is $2.78. The Score for MEIP is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • MEIP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
9
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $3.73. The Score for RVNC is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MEIP Stock Price Chart

What is MEI Pharma's stock price today?

  • The MEI Pharma share price today is $2.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEIP is experiencing selling pressure, which indicates risk of future bearish movement.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $3.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing selling pressure, which indicates risk of future bearish movement.

MEIP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 36.78 Sell
Chaikin Money Flow: -8290 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.8 - 3.1) Sell
Bollinger Bands (100): (2.79 - 3.29) Sell

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 32.99 Sell
Chaikin Money Flow: -1111191 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.97 - 5.77) Sell
Bollinger Bands (100): (3.78 - 6.28) Sell

MEIP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.89 Sell
20-day SMA: 3 Sell
50-day SMA: 2.9 Sell
200-day SMA: 3.26 Sell
8-day EMA: 2.87 Sell
20-day EMA: 2.92 Sell
50-day EMA: 2.95 Sell
200-day EMA: 3.57 Sell

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.98 Sell
20-day SMA: 4.79 Sell
50-day SMA: 5.16 Sell
200-day SMA: 4.6 Sell
8-day EMA: 3.99 Sell
20-day EMA: 4.48 Sell
50-day EMA: 4.92 Sell
200-day EMA: 6.01 Sell

MEI Pharma Earnings Growth & MEIP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.14 per share, and a decrease next year of $8.92 per share.

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.

MEI Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):